Kazakhstan COVID-19 Employer Resources

From the start of February, Kazakhstan is the first country in Central Asia to embark on a major coronavirus vaccination campaign with the Russian Sputnik V vaccine.  In April this year the Ministry of Health of Kazakhstan plans to begin vaccinations with the local coronavirus vaccine QazCOVID-in, which is now in the third stage of clinical trials.

COVID-19 vaccine considerations for Kazakhstan

  • Can employers mandate the vaccine?
  • Who will control delivery of the vaccine?
    Public health service
  • Who covers the cost of the vaccine?
  • Where will people get vaccinated?
    General Practitioner's office (Government clinics)
  • Is there cultural resistance to getting the vaccine?

The major Coronavirus vaccination campaign in Kazakhstan began in February, but the beginning of the March, less than 50 thousand people have been vaccinated. The government says it plans to vaccinate 10 million citizens by the end of the 2021 year. At the first stage, it is planned to vaccinate those categories that are at the forefront: medical workers, police, teachers, military personnel. At the second stage, which plans to start in April 2021, the remaining persons from 18 to 60 years old will be vaccinated.

More Information

Committee of Science of Ministry of Education and Science

coronavirus2020.kz/ru/vaccine, is a website where you can find official information on vaccine in Russian only



This information is provided by GrECo Group, Asinta's partner in Kazakhstan.

Employee Benefits in Kazakhstan

Get insights on mandatory and common supplementary employee benefits in Kazakhstan.

Learn More

Top 6 Vaccine Considerations

Use our decision matrix to help support your employees.

Learn More

Page last modified: March 10, 2021

The information presented on this site is current as of the date initially posted; and, because matters related to COVID-19, the vaccine, and compliance measures are changing so quickly, it may not be current as of the date you read it. While the information gathered here is from Asinta global partners who are subject matter experts in their respective fields, this information is not meant to be a substitute for individual legal or medical advice, or as a substitute for advice in your specific situation.